FdaApplication
ANDA 219167
Identifiers
- fda_app_no: ANDA219167
Properties
| Property | Value |
|---|---|
| applicant_name | GLAND PHARMA LTD |
| application_type | ANDA |
| approval_date | 2026-01-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BORTEZOMIB | BORTEZOMIB | 2.5MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS |
| BORTEZOMIB | BORTEZOMIB | 1MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS |
2 products